Rossner S, Wallgren ASerum lipoproteins and proteins after breast cancer surgery and effects of tamoxifenAtherosclerosis52339-346, 1984
2.
Brun LD, Gagne C, Tousseau C, et al Severe lipemia induced by tamoxifenCancer57.2123-2126, 1986
3.
Noguchi M, Taniya T, Tajiri K, et al. Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen . Br J Surg74586-587, 1987
4.
Glueck CJ, Lang J, Hamer T, et al. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hyperglyceridemic women. J Lab Clin Med123(1) 59-64, 1994
Bertelli G, Pronzato P, Amoroso D, et al Adjuvant tamoxifen in primary breast cancer Influence on plasma lipids and antithrombin III levelsBreast Cancer Res Treat12:307-310, 1988
7.
Bagdade JD, Wolter J, Subbaiah PV, et al. Effects oftamoxifen treatment on plasma lipids and lipoprotein lipid composition. J Clin Endocrinol Metab70.1132-1135, 1990
8.
Thangaraju M, Kumar K, Gandhirajan R, et al Effects of tamoxifen on plasma lipids and lipoproteins in postmenopausal women with breast cancerCancer73(3).659-663, 1994
9.
Love RR, Wiebe DA, Newcomb PA, et al Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med115860-864, 1991
10.
Caleffi M, Fentiman IS, Clark GM, et al Effects of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast painJ. Endocrinol119335-339, 1988
11.
Glueck CJ, Fallat RW, Schell DEffects of estrogenic compounds on triglyceride kinetics. Metabolism24:537-545, 1975
12.
Applebaum DM, Godberg AP, Pykalisto OJ, et al Effects of estrogen on post-heparin lipolytic activity: Selective decline in hepatic triglyceride lipase. L Clin Invest59.601-608, 1977
13.
Swedish Breast Cancer CooperativeGroup J Natl Cancer Inst88:1543-1549, 1996
